Skip to main content

Table 2 Parameters for tumor spread between the PDS and NACT group

From: Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

Parameter

PDS group

NACT group

P value

Pelvic mass ≥ 10 cm

18.4% (26/141)

16.5% (13/79)

0.712

Large volume Ascites (>500 mL)

45.4% (64/141)

45.6% (36/79)

0.980

Multiple peritoneal nodules

56.7%(80/141)

57.0% (45/79)

0.974

Multiple mesenteric nodules

27.0%(38/141)

48.1% (38/79)

0.002

Multiple diaphragm nodules

30.5%(43/141)

43.0% (11/56)

0.061

Omental cake

22.0%(31/141)

79.7% (63/79)

< 0.001

Multisectional intestinal infiltration ≥3 segments

23.4%(33/141)

12.7% (10/79)

0.054

Multiple liver metastasis

14.9%(21/139)

27.8% (22/79)

0.020

Fusion of enlarged lymph node

4.4%(5/113)

1.6% (1/62)

0.226